LUMO (Lumos Pharma, Inc.) Rega marang bathi mangsa ngarep

Lambang korporat lan logo Lumos Pharma Corp (LUMO)

Lumos Pharma, Inc. (LUMO) derives its efficiency from recruiting leading endocrinologists to develop therapies for children with growth retardation. This chart of the company's forward P/E ratio visualizes this trend, where 0.00 captures the current state of the parameter. The fundamentals rely on stringent FDA patent barriers, although liquidity is constrained by dependence on the outcome of a single clinical trial.

LUMO - Rasio prakiraan rega marang bathi Lumos Pharma Inc ing rentang 04.07.2022 - 21.12.2024

Rincian analitis perusahaan Lumos Pharma, Inc.

Analisis umum perusahaan:LUMO lumos-pharma.com
Produk merek Lumos Therapeutics

To assess asset quality, an investor compares current market capitalization with expected earnings, which allows for the determination of market yield expectations under tight monetary policy via the business's forward P/E. The growth of this multiple confirms market confidence in the monetization of robotic molecule screening and the automation of data processing for orphan diseases, which are expected to provide Lumos Pharma, Inc. (LUMO) with sustainable financial growth.

Pesaing Lumos Pharma, Inc. (LUMO)

Prakiraan rega marang bathi ASND (Ascendis Pharma Inc.)|MDGL (Madrigal Corp) - Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep corcept.com CORT|RYTM - Prakiraan rega marang bathi|Akero Corp - Pangali Forward P/E|Rasio prakiraan rega marang bathi Metsera Corp|MLTX (MoonLake) - Prakiraan rega marang bathi|CRNX: Rasio kapitalisasi marang bathi mangsa ngarep|NAMS (NewAmsterdam Pharma Corp) - Pangali Forward P/E|Pangali Forward P/E Soleno Therapeutics|Pangali Forward P/E FOLD|Rega marang bathi mangsa ngarep ETNB (89bio Inc)|Rega marang bathi mangsa ngarep agios.com AGIO|Structure Corp (GPCR) - Rasio prakiraan rega marang bathi|MDXG - Rega marang bathi mangsa ngarep|RZLT: Rega marang bathi mangsa ngarep|LXRX: Pangali Forward P/E|MBX - Kapitalisasi marang proyeksi bathi|Rega marang bathi mangsa ngarep Altimmune Pharma|Aardvark Pharma (AARD) - Kapitalisasi marang proyeksi bathi|Rega marang bathi mangsa ngarep sagimet.com (SGMT)|Prakiraan rega marang bathi BioAge Labs, Inc. BIOA|Pangali Forward P/E BMEA (Biomea Fusion)|Pangali forward rega marang bathi quincetx.com|GUTS - Rega marang bathi mangsa ngarep|vTv Therapeutics, Inc. - Rasio kapitalisasi marang bathi mangsa ngarep|ATPC: Pangali Forward P/E|Pluri Inc (PLUR) - Pangali Forward P/E|Rega marang bathi mangsa ngarep Synlogic, Inc.|Rasio prakiraan rega marang bathi Lipocine LPCN|Rega marang bathi mangsa ngarep Matinas BioPharma Holdings Inc. (MTNB)|Prakiraan rega marang bathi Spruce Biosciences SPRB|Galecto Corp - Prakiraan rega marang bathi|carmellrx.com - Rega marang bathi mangsa ngarep|ONVO: Prakiraan rega marang bathi|Pangali mangsa ngarep rega marang bathi RDUS (Radius Recycling Inc.)